Unknown

Dataset Information

Crystal structures of a llama VHH antibody BCD090-M2 targeting human ErbB3 receptor.


ABSTRACT: Background: The ability of ErbB3 receptor to functionally complement ErbB1-2 and induce tumor resistance to their inhibitors makes it a unique target in cancer therapy by monoclonal antibodies. Here we report the expression, purification and structural analysis of a new anti-ErbB3 single-chain antibody. Methods: The VHH fragment of the antibody was expressed in E. coli SHuffle cells as a SUMO fusion, cleaved by TEV protease and purified to homogeneity. Binding to the extracellular domain of ErbB3 was studied by surface plasmon resonance. For structural studies, the antibody was crystallized by hanging-drop vapor diffusion in two different forms. Results: We developed a robust and efficient system for recombinant expression of single-domain antibodies. The purifi

SUBMITTER: Eliseev IE 

PROVIDER: S-EPMC6097396 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature